Supplemental material
Open access
471
Views
0
CrossRef citations to date
0
Altmetric
Short Communication
Comparison of time to clinically meaningful improvement in quality of life in neurological disorders in patients treated with natalizumab versus ocrelizumab
Carrie M Hersh1 Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, NV 89106, USACorrespondence[email protected]
https://orcid.org/0000-0002-5716-5645View further author information
, https://orcid.org/0000-0002-5716-5645View further author information
Menglan Pang2 Biogen, Cambridge, MA 02142, USAView further author information
, Deborah M Miller3 Mellen Center, Cleveland Clinic, Cleveland, OH 44195, USAView further author information
, Marisa P McGinley3 Mellen Center, Cleveland Clinic, Cleveland, OH 44195, USAView further author information
, Megan Hyland4 Department of Neurology, University of Rochester Medical Center, Rochester, NY 14642, USAView further author information
, Tjalf Ziemssen5 University Clinic Carl-Gustav Carus, Dresden, 01307, GermanyView further author information
& Robin L Avila2 Biogen, Cambridge, MA 02142, USAView further author information
show all
Received 28 Dec 2023, Accepted 13 Mar 2024, Published online: 16 Apr 2024
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.